IMM 2.38% 32.3¢ immutep limited

Ann: Prima initiates Phase I melanoma study in Australia, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 25,570 Posts.
    lightbulb Created with Sketch. 1398
    Channel 7 news tonight had a story about keytruda and its success with some
    melanoma patients, interviewed one patient who to all intents and purposes
    is cured.....She commented that she felt great about it but also that she felt
    for others in the same treatment that didn't have the same result...
    Dr Atkinson from the Greenslopes hospital was also interviewed and
    she said they were also trialing other things with keytruda which were
    further away....
    Dr Atkinson is in charge of the tacti-mel trial using Imp321 as a
    combination therapy.....
    Which by the way we are due interim news in the near future....
    Hopefully it's promising news.....
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.3¢
Change
0.008(2.38%)
Mkt cap ! $469.0M
Open High Low Value Volume
31.5¢ 32.5¢ 31.0¢ $797.0K 2.508M

Buyers (Bids)

No. Vol. Price($)
8 56100 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 470694 26
View Market Depth
Last trade - 14.25pm 19/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.